C

Carisma Therapeutics
D

CARM

0.50500
USD
0.07
(15.51%)
مغلق
حجم التداول
5,260
الربح لكل سهم
-0
العائد الربحي
-
P/E
-0
حجم السوق
21,102,988
المقالات

العنوان: Carisma Therapeutics

القطاع: Healthcare
الصناعة: Biotechnology
CARISMA Therapeutics Inc is a clinical-stage cell therapy company focused on utilizing Carisma's proprietary chimeric antigen receptor macrophage and monocyte cell engineering platform to develop transformative immunotherapies to treat cancer and other serious diseases. The company has created a comprehensive cell therapy platform to enable the therapeutic use of engineered macrophages and monocytes, which belong to a subgroup of white blood cells called myeloid cells.